or Try an Advanced Search...

    Technical Analysis for 0H8E - Accelerate Diagnostics Inc.

    Grade Last Price % Change Price Change
    F 0.92 8.53% 0.07
    0H8E closed up 8.53 percent on Monday, April 22, 2024, on 13 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    Earnings due: May 9
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong N/A Down Down
    Historical 0H8E trend table...
    Date Alert Name Type % Chg
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Up Strength 0.00%
    Oversold Stochastic Weakness 0.00%
    Narrow Range Bar Range Contraction 8.53%
    Wide Bands Range Expansion 8.53%
    Oversold Stochastic Weakness 8.53%
    Narrow Range Bar Range Contraction 7.44%
    Stochastic Reached Oversold Weakness 7.44%
    Wide Bands Range Expansion 7.44%
    Older End-of-Day Signals for 0H8E ...

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    TradingView chart

    Profile

    Accelerate Diagnostics Inc. Description

    Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. The company was incorporated in 1982 and is headquartered in Tucson, Arizona.

    Classification
    Keywords: Infection Infectious Diseases Antibiotic Bacterial Diseases Healthcare Associated Infections Antimicrobial Resistance In Vitro Diagnostics

    Is 0H8E a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 7.0822
    52 Week Low 0.46
    Average Volume 1,314
    200-Day Moving Average 0.00
    50-Day Moving Average 3.14
    20-Day Moving Average 1.08
    10-Day Moving Average 0.98
    Average True Range 0.15
    RSI (14) 30.07
    ADX 35.47
    +DI 31.84
    -DI 62.59
    Chandelier Exit (Long, 3 ATRs) 0.98
    Chandelier Exit (Short, 3 ATRs) 1.31
    Upper Bollinger Bands 1.37
    Lower Bollinger Band 0.78
    Percent B (%b) 0.25
    BandWidth 55.28
    MACD Line -0.43
    MACD Signal Line -0.52
    MACD Histogram 0.0842
    Fundamentals Value
    Market Cap 500.57 Thousand
    Num Shares 54.1 Million
    EPS -1.06
    Price-to-Earnings (P/E) Ratio -0.88
    Price-to-Sales 0.08
    Price-to-Book 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.94
    Resistance 3 (R3) 0.94 0.93 0.93
    Resistance 2 (R2) 0.93 0.93 0.93 0.93
    Resistance 1 (R1) 0.93 0.92 0.93 0.93 0.93
    Pivot Point 0.92 0.92 0.92 0.92 0.92
    Support 1 (S1) 0.92 0.92 0.92 0.92 0.92
    Support 2 (S2) 0.91 0.92 0.91 0.92
    Support 3 (S3) 0.91 0.91 0.91
    Support 4 (S4) 0.91